HEALTHSCIENCE DAILY
New depression treatment targets the immune system instead of the brain
A new depression treatment approach targeting the immune system instead of brain chemicals showed early promise in a small clinical trial. An anti-inflammatory drug used for rheumatoid arthritis reduced depression symptoms, fatigue, anxiety, and improved quality of life in participants.
Mentioned
Related Signal
Adjacent reporting
- For the first time, scientists pinpoint the brain cells behind depression
- Weight loss drug Ozempic linked to lower depression and anxiety risk
- STAT+: Pharmalittle: We’re reading about RFK Jr. targeting antidepressants, J&J pushing an IBD drug, and more
- Harvard scientists link gut bacteria to depression through hidden inflammation trigger
- New psychedelic-like drugs could treat depression without making you trip
- Brain cells grown in a lab dish and made to play arcade games could help understand ADHD, autism and depression, scientists say